v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income (loss) [1] $ 18,723 $ 357,440
Adjustments to net income (loss):    
Depreciation and amortization 476,479 490,046
Deferred income tax expense (benefit) 9,983 103,566
Impairments and other charges (26) 31,102
Amortization of debt discount and deferred financing costs 5,292 6,681
Bargain purchase gain   (116,499)
Losses (gains) on debt buyback 7,182 1,948
Losses (gains) on sale of long-lived assets, net 704 (13,362)
Share-based compensation 13,335 14,623
Foreign currency transaction losses (gains), net 5,117 5,347
Mark-to-market (gain) loss on warrants (672) (7,424)
Gain on disposition of Quail Tools, excluding transaction costs   (415,557)
Other (336) 3,974
Changes in operating assets and liabilities, net of effects from acquisitions:    
Accounts receivable [2] (115,289) (15,813)
Inventory 7,548 19,904
Other current assets (8,038) (22,651)
Other long-term assets (195) 15,596
Trade accounts payable and accrued liabilities 51,929 (4,553)
Income taxes payable 9,788 1,980
Other long-term liabilities 5,950 (8,923)
Net cash provided by (used for) operating activities 487,474 447,425
Cash flows from investing activities:    
Purchases of investments (7,000) (4,336)
Cash acquired in stock based business combination, net of cash paid   84,429
Proceeds from disposition of Quail Tools   371,319
Capital expenditures (460,803) (553,886)
Proceeds from sales of assets and insurance claims 11,975 50,609
Other (894) 7,502
Net cash (used for) provided by investing activities (456,722) (44,363)
Cash flows from financing activities:    
Reduction in debt (484,013) (343,036)
Proceeds from revolving credit facilities   398,000
Reduction in revolving credit facilities   (398,000)
Payment of dividend to former Parker shareholders   (6,052)
Payments for employee taxes on net settlement of equity awards (3,627) (2,151)
Distributions to noncontrolling interest (4,776) (1,625)
Special purpose acquisition company redemptions by non-controlling redeemable shareholders   (186,655)
Other 5  
Net cash (used for) provided by financing activities (492,411) (539,519)
Effect of exchange rate changes on cash and cash equivalents (3,734) (2,669)
Net increase (decrease) in cash and cash equivalents and restricted cash (465,393) (139,126)
Cash and cash equivalents and restricted cash, beginning of period 942,844 722,960
Cash and cash equivalents and restricted cash, end of period 477,451 583,834
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH    
Cash and cash equivalents, beginning of period 940,707 389,652
Restricted cash, beginning of period 2,137 333,308
Cash and cash equivalents and restricted cash, beginning of period 942,844 722,960
Cash and cash equivalents, end of period 475,072 428,051
Restricted cash, end of period $ 2,379 $ 155,783
Restricted cash, Balance Sheet location Other current assets, Other long-term assets Other current assets, Other long-term assets
Cash and cash equivalents and restricted cash, end of period $ 477,451 $ 583,834
[1] The condensed consolidated income statements include operating activities of consolidated joint ventures. See Note 4—Joint Ventures for additional information.
[2] Includes changes in related party balances of $90.5 million and $3.4 million for the nine months ended September 30, 2026 and 2025, respectively.